"Fewer U.S. Medical Oncologists Engaging With Industry Since the Inception of Open Payments" - Kara Nyberg, PhD
A study performed by researchers at the Icahn School of Medicine at Mount Sinai found that financial ties between industry and U.S. medical oncologists have shifted from 2014 to 2017 with the implementation of the Open Payments disclosure program. “The intent of transparency through Open Payments and the implication of showing the program’s impact over time is ultimately to preserve the public’s trust in physicians and to protect the integrity of physician decision-making,” said lead author Deborah Marshall, MD, resident, radiation oncology, Icahn School of Medicine at Mount Sinai. She added, “We are likely going to see the continued impact of Open Payments over time. Given that physician behavior is influenced by that of one’s peers, we hope that these findings will encourage physicians to consider their relationships more closely.”
— Deborah C. Marshall, MD, Resident, Radiation Oncology, Icahn School of Medicine at Mount Sinai